Daniel Vitt - Jan 2, 2023 Form 4 Insider Report for IMMUNIC, INC. (IMUX)

Role
Chief Executive Officer, Director
Signature
/s/ Daniel Vitt
Stock symbol
IMUX
Transactions as of
Jan 2, 2023
Transactions value $
$0
Form type
4
Date filed
1/6/2023, 08:30 PM
Previous filing
Nov 23, 2022
Next filing
Jan 19, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMUX Stock Option Award $0 +300K $0.00 300K Jan 2, 2023 Common Stock 300K $1.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months.